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to characterise wild type and mutant proteins by polarographic and
voltametric techniques to investigate the importance of these
residues in ubiquinone-binding. Q242N, S256T and R262K substitu-
tion results in complete loss of AOX electron transfer activity that is
not due to instability of the protein suggesting that these residues,
also identiﬁed as being important in complex II, are critical for Q-
binding in AOX. Of equal interest was the ﬁnding that N247Q
substitution had little effect upon electron transfer or inhibitor
sensitivity. We are currently investigating the importance of this
residue since we believe it is responsible for a difference in
sensitivity to ascofuranone, a very speciﬁc inhibitor of the
alternative oxidase, in Trypanosoma brucei and Trypanosoma vivax.
Results will also be presented as to the importance of Y253 and
H262 in Q-binding.Supported by the BBSRC.
doi:10.1016/j.bbabio.2008.05.294
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The aim of this project is to elucidate the structure of the
alternative oxidase under optimal crystallographic conditions. The
alternative oxidase (AOX), an inner-mitochondrial membrane ubi-
quinol:oxygen oxidoreductase, is responsible for cyanide-resistant
respiration in plants, several fungi and a variety of alpha-
proteobacteria. Importantly, several human parasites, including
Trypanosoma brucei brucei and Blastocystis hominis, also functionally
express the alternative oxidase gene. In the case of trypanosomes,
the causative agent of African sleeping sickness, AOX has been found
to be the sole oxidase present in the bloodstream form of the
kinetoplast parasite. While the alternative oxidase has been
modeled in silico, the exact structure remains unknown. Detailed
knowledge of the structure is essential to the future study of the
enzyme, speciﬁcally in relation to rational drug design of effective
anti-parasitic drugs. Sauromatum guttatum AOX has been over-
expressed in both C41 and heme-deﬁcient Escherichia coli strains,
solubilised in the presence of a variety of detergents, and
subsequently puriﬁed using cobalt afﬁnity gel. Results will be
presented to show the production of an active protein at all stages
of the puriﬁcation process, in addition to demonstrating for the ﬁrst
time that the plant AOX is sensitive to the speciﬁc trypanosomal
inhibitor ascofuranone. This work is supported by a grant from the
BBSRC.
doi:10.1016/j.bbabio.2008.05.295
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The diabetic kidney has an altered energy metabolism which
is partly due to the increased tubular electrolyte load, but also
due to activation of several seemingly different pathways. We
have previously shown that increased oxidative stress and
activation of the polyol pathway result in reduced tissue oxygen
tension throughout the diabetic kidney. Interestingly, we found
that the reduced oxygen availability always was linked to
increased oxygen utilization, even during situations of glomeru-
lar hypoﬁltration, i.e. when the tubular load of electrolytes was
reduced.
We could show that the increased oxygen utilization in the
diabetic kidney in vivo is dependent on reduced nitric oxide
bioavailability, and thus reduced inhibition of mitochondria respira-
tion, but exogenous stimulation of the nitric oxide production was
not sufﬁcient to alone normalize the oxygen tension. When
investigating the cellular oxygen metabolism in the diabetic kidney
at the molecular level, we found that the diabetic kidney has
increased uncoupling protein (UCP)-2 expression. Oxygen consump-
tion by diabetic mitochondria can be stimulated by glutamate alone,
which is in vast contrast to mitochondria from normoglycemic
controls. The glutamate-stimulated oxygen consumption by the
diabetic mitochondria is prevented by either addition of GDP or
removal of the free fatty acids, which further supports the
conclusion of mitochondrial uncoupling. Although remaining to be
supported by future experiments, we propose that the increased
UCP-2 expression in the diabetic kidney is an antioxidant defense,
which serves to reduce the mitochondria superoxide radical
production and thereby preserve the function of the electron
transport chain.
doi:10.1016/j.bbabio.2008.05.296
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We used different human cells to elucidate the molecular
mechanism responsible for biochemical and clinical phenotypes
associated with mutations at nt8993 in the mitochondrial DNA
(mtDNA). The most common human mutations at this nucleotide,
TNG and TNC, change Leu-156 for Arg and Pro, respectively, in
the ATPase6 subunit (homologous to subunit a of E. coli) of the
F1F0-ATPase (ATP synthase). When Pro substitutes for Leu, both
clinical and biochemical phenotypes are rather mild, and ATP
synthesis rate is found less than 20% reduced, matching the
decrease of proton translocation rate through F0 during ATP
synthesis. At variance, the mtDNA 8993TNG mutation, bringing
in the ATPase6 subunit Arg-156 and being associated with severe
syndromes of infancy and childhood, induces a dramatic decrease
of ATP synthesis rate, an impaired proton translocation rate, but
an almost normal ATP hydrolysis rate. Taking into account the
above observations, and on the basis of structural prediction
analysis of mutant ATPase6 subunit, we suggest that the proton
translocation pathway through F0 is impaired by the TNG
mutation, possibly due to partial loss of the Leu-156-containing
transmembrane helix, which is essential for energy transduction
by the ATP synthase. In conclusion, our study demonstrates the
important role of Leu-156 for the ATPase6 structure allowing
mitochondrial F1F0-ATPase energy transduction, and it provides a
molecular mechanism for the pathogenesis of severe human
syndromes. Moreover, our results suggest that mitochondrial
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diseases associated with the only TNG mutation are primarily
caused by a severe bioenergetic deﬁciency.
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Opening of the mitochondrial permeability transition pore (MPTP)
plays a key role in cell death, especially necrosis, and mediates the
injury tissues such as the heart and brain experience following
ischaemia and reperfusion. However, the molecular identity of the
MPTP remains uncertain. Knockout studies have conﬁrmed a role for
cyclophilin-D (CyP-D), probably mediated by its peptidyl-prolyl cis-
trans isomerase activity that facilitates a conformational change in an
inner membrane protein. However, knockout studies have cast doubt
on the central role of the adenine nucleotide translocase (ANT),
previously implicated as the channel-forming component of theMPTP.
The evidence for and against a role for the ANT inMPTP openingwill be
reviewed and data presented to suggest that it usually plays a
regulatory role rather than provide the transmembrane pore compo-
nent. Our recent data suggest that the protein fulﬁlling the latter role is
the mitochondrial phosphate carrier (PiC) and recent evidence in
support of this proposal will be summarised. Our data are consistent
with a model for the MPTP in which a calcium-triggered conforma-
tional change of the PiC, facilitated byCyP-D, induces pore opening.We
propose that this is enhanced by an association of the PiC with the “c”
conformation of the ANT. Agents that modulate pore opening may act
on either or both the PiC and the ANT.
doi:10.1016/j.bbabio.2008.05.298
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When the mitochondrial membrane potential (Δψm) is compro-
mised, the F1FoATP synthase runs in reverse, and mitochondria switch
from ATP producers to consumers. In studies of the isolated enzyme,
the protein IF1 inhibits ATPase activity at an acidic pH. As its impact on
mitochondrial function in intact cells is not established, we have
explored the effect of overexpression or knockdown of IF1 in cell lines
(HeLa, C2C12). Upon inhibition of respiration, IF1 conserves ATP
(measured using luciferase transfected cells or measurements of
[Mg2+]c) at the expense of mitochondrial depolarisation and reduces
hypoxic cell death. Knocking down the protein promoted conservation
of Δψm at the expense of ATP. Surprisingly, IF1 also had a profound
impact on mitochondrial structure and function: IF1 overexpression
increased both the number of mitochondrial cristae and ATP synthase
activity, decreasing Δψm and favouring a dependence of ATP home-
ostasis on oxidative phosphorylation. Knocking down the protein had
the opposite effect. Further, using immunoﬂuorescence, we found that
the relative expression of IF1 to ATPase is considerably greater in
primary neuronal cultures compared to adjacent astrocytes, showing
that IF1 expression level is not ﬁxed in relation to the ATPase. These
observations show that IF1 has an inﬂuence onmitochondrial function
at rest and that it is effective at preserving cellular ATP in hypoxic or
ischaemic conditions.
doi:10.1016/j.bbabio.2008.05.299
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Cellular glutamate pathways are essentially controlled by
mitochondrial metabolism. Although enzymes of the mitochondrial
matrix have been studied quite extensively, the regulation of
mitochondrial membrane carriers is still rather mysterious. More-
over, recent advances show that it is inappropriate to extrapolate
regulation models acquired from one cell model to another, as every
tissue uses glutamate for speciﬁc functions. Very little is known
about molecular mechanisms responsible for tissue speciﬁcities. For
instance, expression of different isoforms of glutamate carriers
might contribute to tissue speciﬁcity. Regarding glutamate dehy-
drogenase, ﬂux direction depends on metabolic parameters such as
substrate availability, redox and energy state of mitochondria. These
parameters may be tissue speciﬁc. At the post-translational level,
new modes of regulations have been described these recent years.
Indeed, ADP-ribosylation of GDH mediated by SIRT4 offers another
regulatory mechanism that might be tissue speciﬁc, pending
different levels of SIRT4 expression. This newly identiﬁed mode of
regulation certainly deserves further investigations to better
integrate molecular and cellular glutamate pathways into metabolic
homeostasis at the organism level.
doi:10.1016/j.bbabio.2008.05.300
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Pancreatic beta cells secrete insulin when blood glucose levels are
high. Dysfunction of this glucose-stimulated insulin secretion (GSIS) is
partly responsible for themanifestation of type 2 diabetes, ametabolic
disorder that is rapidly becoming a global pandemic. Mitochondria
play a central role in GSIS by coupling glucose oxidation to production
of ATP, a signal that triggers a series of events that ultimately leads to
insulin release. Beta cells express a mitochondrial uncoupling protein,
UCP2, which is rather surprising as activity of such a protein is
anticipated to lower the efﬁciency of oxidative phosphorylation, and
hence to impair GSIS. The mounting evidence demonstrating that
insulin secretion is indeed blunted by UCP2 agrees with this
prediction, and has provoked the idea that UCP2 activity contributes
to beta cell pathogenesis and development of type 2 diabetes.
Although this notion may be correct, the evolved function of UCP2
remains unclear. In this lecture, data will be presented that were
obtained from our RNA interference studies to probe the effect of Ucp2
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